Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately
The FDA has categorized this as a Class I recall. If patients update their phone or watch apps as needed, they can continue to use these devices like normal.
Plant-based diets linked to lower risks of death, heart disease, stroke and diabetes
Diets that prioritize plant-based foods are associated with several health benefits, according to a new study of more than 3.4 million adults. Such diets also show potential to reduce greenhouse gas emissions.
Health systems use AI to target patients who may have elevated Lp(a) levels
"We can start helping people right now, and it would be meaningful if we can raise more awareness to reduce the burden of CVD," explained Katherine Wilemon, founder and CEO of the Family Heart Foundation.
Oral GLP-1 drug linked to weight loss in patients with and without diabetes—is FDA approval next?
Eli Lilly and Company is back with even more positive data on orforglipron, its oral GLP-1 receptor agonist. The company says it is "moving with urgency" toward gaining key regulatory approvals and getting the drug in the hands of patients.
Cardiology group thanks Taylor Swift for spreading word about nuclear stress testing
When Taylor Swift speaks, the world listens. And when she recently appeared on a podcast for the very first time, she shared the story of how a nuclear stress test saved her father's life.

AHA: Nutrition education for med students often overlooked

A healthy diet is a cornerstone to preventing cardiovascular disease, but many healthcare providers receive insufficient nutrition education and training, according to a new scientific advisory released by the American Heart Association.

Real-World Study Shows INVOKANA® (canagliflozin) 300mg Demonstrates Better Blood Glucose Control Than Farxiga® (dapagliflozin) 10mg in Patients with Type 2 Diabetes

TITUSVILLE, N.J., April 27, 2018 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the results of a real-world study showing that adults with type 2 diabetes initiated on INVOKANA® (canagliflozin) 300mg had significantly better blood glucose control, based on A1C goal attainment and reduction, compared to similar patients initiated on Farxiga®(dapagliflozin) 10mg.

Prediabetes, hypertension combo increases risk of cardiovascular disease

A combination of prediabetes and hypertension increases the risk for cardiovascular disease (CVD) more than either risk factor alone, according to new research published April 18 in Hypertension.

Patients with 'white-coat syndrome' 79% more likely to die of hypertension

Ambulatory blood pressure measurements are a stronger predictor of all-cause and cardiovascular mortality than clinical blood pressure measurements, according to a study published April 19 in the New England Journal of Medicine.

6% of children have new or worsening hypertension under updated guidelines

Although they didn’t garner as much attention as the adult guidelines, the criteria for determining hypertension in children also changed in 2017. They led to an increase in individuals considered outside the normal range, according to a study published online April 23 in JAMA Pediatrics.

Mindfulness may positively impact cardiovascular health

New research from Michigan Technological University suggests an hour of mindfulness meditation can reduce anxiety and positively impact cardiovascular health—in particular, blood pressure. Study findings were presented April 23 at the 2018 Experimental Biology Meeting in San Diego.

Metabolically healthy obesity often a ‘transient state’ on slide to CVD

Metabolically healthy obesity (MHO) is not a stable state—rather, it's a slippery slope toward metabolic syndrome and increased risk of cardiovascular disease (CVD), suggests a long-term study published April 23 in the Journal of the American College of Cardiology.

Psychosocial risk factors may impact weight management in children

Children whose families have increased psychosocial risks are three times more likely to discontinue weight management treatment and are also less likely to improve their weight status, according to new research published April 5 in the Journal of Pediatrics.

Heart Health

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately

Plant-based diets linked to lower risks of death, heart disease, stroke and diabetes

Health systems use AI to target patients who may have elevated Lp(a) levels

Oral GLP-1 drug linked to weight loss in patients with and without diabetes—is FDA approval next?

Cardiology group thanks Taylor Swift for spreading word about nuclear stress testing